Blue MedicareRx Value Plus 2026 Medicare Part D Plan Available in Vermont
The Medicare Part D plan Blue MedicareRx Value Plus is offered by Blue MedicareRx for the 2026 plan year and is available in Vermont. It covers prescription drugs, with costs structured around premiums, a deductible, and tier-based copayments or coinsurance.
Updated: .
| Blue MedicareRx Value Plus: Part D Plan Overview | |
|---|---|
| Part D Plan ID: | S2893-001 |
| Plan Year: | 2026 |
| Total Part D Premium: | $20.70 |
| Annual Deductible: | $615.00 |
| Part D Benefit Type: | Basic |
| No Deductible Drug Tier: | Yes |
| Low Income Subsidy: | Yes |
| Insured By: | Blue MedicareRx |
Prescription Drug Costs
Blue MedicareRx Value Plus includes prescription drug costs beyond the monthly premium, such as a deductible and tier-based copayments or coinsurance. The tables below show how costs are structured for covered medications under this plan.
Monthly Premium
The 2026 Medicare Part D plan Blue MedicareRx Value Plus includes a monthly premium. The table below outlines the premium amount for this plan.
| Basic Part D Premium: | $20.70 |
| Supplemental Part D Premium: | $0.00 |
| Total Part D Premium: | $20.70 |
| Low Income Premium Subsidy: | $35.76 |
| Low Income Premium Subsidy CMS Pays: | $20.70 |
| Low Income Subsidy Premium: | $0.00 |
Low-Income Subsidy (LIS), also called “Extra Help,” may reduce prescription drug costs for eligible beneficiaries. See the Social Security Extra Help page for details.
Annual Deductible
The annual deductible for Blue MedicareRx Value Plus is $615.00. You are responsible for this cost before the plan shares prescription drug expenses.
Prescription Drug Cost Sharing
In addition to premiums and any deductible, Blue MedicareRx Value Plus includes copayments or coinsurance for covered medications. The table below shows cost-sharing by drug tier.
| Drug Tier | Retail | Mail Order | |
|---|---|---|---|
| Preferred Generic* | $1.00 | $1.00 | |
| Generic | $5.00 | $5.00 | |
| Preferred Brand | 22.00% | 22.00% | |
| Non-Preferred Drug | 35.00% | 35.00% | |
| Specialty Tier | 25.00% | 25.00% | |
| *Deductible does not apply. | |||
CMS Star Ratings
Medicare assigns star ratings to Part D plans on a 1 to 5 scale, with 5 stars representing the highest quality. Ratings are based on measures such as customer service, member experience, and drug safety. The table below shows the rating for Blue MedicareRx Value Plus.
| CMS Measure | Star Rating |
|---|---|
| Overall Plan Rating | |
| Drug Plan Customer Service | |
| Complaints and Changes in the Drug Plan | |
| Member Experience with the Drug Plan | |
| Drug Safety and Accuracy of Drug Pricing |
Contact Information for Blue MedicareRx
| Website: | Blue MedicareRx Plan Page |
|---|---|
| Formulary: | Blue MedicareRx Formulary Page |
| Pharmacy: | Blue MedicareRx Pharmacy Page |
| Prospective Part D Members: | (877)479-2227 |
| Prospective Part D TTY Users: | 711 |
- CMS.gov, Landscape Source Files — Last accessed May 2, 2026
- CMS.gov, Medicare Part C & D Performance — Last accessed May 2, 2026
- CMS.gov, Plan Benefits Package — Last accessed May 2, 2026
- CMS.gov, Monthly Enrollment by Contract/Plan/State/County — Last accessed May 2, 2026
Data sources and methodology documentation..
- Blue MedicareRx (official source), http://www.RxMedicarePlans.com — Last accessed April 27, 2026
- Medicare.gov, "Explore your Medicare coverage options" — Last accessed May 2, 2026
- Medicare.gov, "What Medicare Part D drug plans cover" — Last accessed May 1, 2026
- Medicare.gov, "What does Medicare cost?" — Last accessed May 1, 2026
MedicarePlans.com is an independent, non-government informational resource and is not affiliated with or endorsed by the U.S. Government or the federal Medicare program.
Data provenance documentation is maintained in alignment with the U.S. Core Data for Interoperability (USCDI) Provenance standard.
Page content independently curated and maintained by David W. Bynon, Editorial Steward, using a standardized, data-driven methodology for accurate, non-commercial Medicare plan interpretation and resolution.